文献速递中医内科针灸推拿中医康复

针灸对冠心病患者糖脂代谢影响的系统评价与Meta分析

Effectiveness of acupuncture on glycolipid metabolism in patients with coronary heart disease: A systematic review and meta-analysis.
PubMed 文献 · Complement Ther Med · 2024-11-29

该系统评价纳入18项RCT共1346例冠心病患者,评估针灸对糖脂代谢的影响。结果显示针灸联合标准治疗可降低LDL-C、HbA1c及TC、TG、hs-CRP、2hPG水平并提高ORR,但对HDL-C的效应不优于标准治疗。结论认为针灸可作为调节糖脂代谢的辅助治疗,但需大规模长期RCT验证。

要点

  • 针灸联合标准治疗可降低冠心病患者LDL-C(SMD=-0.56)和HbA1c(MD=-1.15)。
  • 联合治疗还改善TC、TG、hs-CRP、2hPG及ORR,但未显示降低HDL-C优势。
  • 针灸可作为冠心病糖脂代谢紊乱的辅助治疗,需更多高质量RCT验证。

核心结论

  • 针灸能有效调节冠心病患者的糖脂代谢,可作为辅助治疗。
  • 针灸可能通过脂质代谢调节促进PCI术后恢复,但需严格的大规模长期RCT验证。

研究设计与样本

  • 系统评价与Meta分析,检索8个数据库至2023年8月18日,无语言限制。
  • 纳入18项RCT,共1346例受试者,仅纳入针灸作为唯一或辅助干预影响冠心病糖脂代谢的RCT。
  • 主要结局为LDL-C和HbA1c,遵循PRISMA声明,使用Cochrane手册、ROB.2、RevMan 5.3和GRADE标准。

主要发现

  • 针灸联合标准治疗降低LDL-C(SMD=-0.56;95%CI,-0.75至-0.38;P<0.00001)。
  • 针灸联合标准治疗降低HbA1c(MD=-1.15;95%CI,-1.73至-0.58;P<0.0001)。
  • 联合治疗改善TC(SMD=-0.97;95%CI,-1.44至-0.51;P<0.0001)、TG(MD=-0.39;95%CI,-0.58至-0.20;P<0.0001)。
  • 联合治疗改善hs-CRP(MD=-0.98;95%CI,-1.43至-0.52;P<0.0001)、2hPG(MD=-1.45;95%CI,-1.74至-1.16;P<0.00001)及ORR(RR=1.27;95%CI,1.19至1.36;P<0.00001)。
  • 联合治疗未在降低HDL-C方面优于标准治疗(MD=0.11;95%CI,0.07至0.14;P<0.00001)。

关键数值与推荐

  • 主要结局LDL-C的SMD=-0.56(95%CI,-0.75至-0.38;P<0.00001)。
  • 主要结局HbA1c的MD=-1.15(95%CI,-1.73至-0.58;P<0.0001)。
  • ORR的RR=1.27(95%CI,1.19至1.36;P<0.00001)。

临床怎么用

  • 对冠心病伴糖脂代谢紊乱患者,可考虑在标准治疗基础上联合针灸作为辅助治疗。
  • 针灸可能有助于改善LDL-C、HbA1c、TC、TG、hs-CRP、2hPG及ORR,但不应替代标准治疗。

局限性

  • 结论需严格的大规模长期RCT进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Disorders of glycolipid metabolism are important pathogenic factors leading to coronary artery disease, and there is no safe and effective comprehensive treatment, while acupuncture has a certain efficacy in heart disease and disorders of glycolipid metabolism. To assess the effects of acupuncture on glycolipid metabolism in patients with coronary heart disease, we conducted a systematic review and meta-analysis. METHODS: From the time of library construction to August 18, 2023, Searches were conducted in eight databases, with no language restriction. Only RCTs that included acupuncture as a sole or secondary effect on glucose-lipid metabolism in coronary heart disease were included.Our primary outcome indicators were Low-density lipoprotein cholesterol(LDL-C), Hemoglobin A1c(HbA1c). Our analyses were conducted in strict accordance with the PRISMA statement, and the researchers used the Cochrane Handbook for literature screening and data extraction, the "Risk of Bias" tool (ROB.2) for assessing risk of bias, and RevMan (version 5.3) for meta-analysis of outcome metrics, and the GRADE criteria for assessing quality of evidence. Assessing the quality of acupuncture literature using the Standards for reporting interventions in clinical trials of acupuncture. RESULTS: Our analysis included 18 eligible RCTs (N = 1346 participants). For the primary outcome metrics, acupuncture combined with standard treatment was effective in reducing LDL-C (SMD =-0.56; 95 % CI, -0.75 to -0.38; P < 0.00001), and HbA1c (MD = -1.15; 95 % CI, -1.73 to -0.58; P < 0.0001). For secondary outcome measures, combination therapy improved TC (SMD = -0.97; 95 % CI, -1.44 to -0.51; P < 0.0001), TG (MD = -0.39; 95 % CI, -0.58 to -0.20; P < 0.0001), hs-CRP (MD = -0.98; 95 % CI, -1.43 to -0.52; P <0.0001), 2hPG (MD = -1.45; 95 % CI, -1.74 to -1.16; P < 0.00001), and ORR (RR, 1.27; 95 % CI, 1.19-1.36; P < 0.00001) levels more than standard therapy alone.However, the combination therapy did not prevail in lowering HDL-C (MD = 0.11; 95 % CI, 0.07-0.14; P < 0.00001) compared with standard therapy alone. Meanwhile heterogeneity analysis showed that After coronary heart disease intervention, acupuncture was able to reduce TC (SMD = -0.85; 95 % CI, -1.37 to -0.33; P = 0.001), TG (MD = -0.14; 95 % CI, -0.24 to -0.04; P = 0.004) levels, but did not dominate in lowering LDL-C. CONCLUSIONS: Acupuncture effectively regulates glycolipid metabolism in coronary artery disease, serving as an adjuvant treatment. It may aid post-PCI healing via lipid metabolism regulation, but rigorous, large-scale, long-term RCTs are needed for validation.

来源:Complement Ther Med,查看原文。版权归原作者所有。

引用

  1. Sun Y, Liu Y, Xiong J, et al. Effectiveness of acupuncture on glycolipid metabolism in patients with coronary heart disease: A systematic review and meta-analysis. Complement Ther Med. 2024. PMID: 39615634. doi:10.1016/j.ctim.2024.103115

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。